Glycine

Glycine

SCHEMBL1675339

NCC(=O)O.O=C(OC1CCN[C@@H]1C(=O)O)[C@@H]1CCCN1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
ARG1 P05089 5/20 0.38
SLC1A2 P43004 1/20 0.36
NOS2 P35228 2/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
ARG2 P78540 1/20 0.32
DPP4 P27487 1/20 0.31
DPP8 Q6V1X1 1/20 0.31
DPP9 Q86TI2 1/20 0.31
GLI1 P08151 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1491950 0.92 MEN1 (0.47) MEN1BLMKMT2AARG1SLC1A2
SCHEMBL6515403 0.87 MEN1 (0.42) MEN1BLMKMT2AARG1SLC1A2
SCHEMBL4398036 0.87 MEN1 (0.35) MEN1BLMKMT2AARG1SLC1A2
Serine SCHEMBL5144903 0.84 MEN1 (0.36) MEN1BLMKMT2AARG1SLC1A2
Proline SCHEMBL6690171 0.83 MEN1 (0.32) MEN1BLMKMT2AARG1
Threonine SCHEMBL6689276 0.80
SCHEMBL1537353 0.76 SLC1A2 (0.44) MEN1BLMKMT2AARG1SLC1A2
Proline SCHEMBL28467818 0.76 MEN1 (0.44) MEN1BLMKMT2AARG1SLC1A2
Proline SCHEMBL4398037 0.76 MEN1 (0.44) MEN1BLMKMT2AARG1SLC1A2
Proline SCHEMBL1196246 0.76 MEN1 (0.44) MEN1BLMKMT2AARG1SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458197-B2 Elastin digest compositions and methods utilizing same HUMAN MATRIX SCIENCES, LLC (US) 2016-10-04 US disclosed
US-20150110755-A1 ELASTIN PRODUCING FIBROBLAST FORMULATIONS AND METHODS OF USING THE SAME NULASTIN, INC. 2015-04-23 US disclosed
US-9006170-B2 Compositions for elastogenesis and connective tissue treatment HUMAN MATRIX SCIENCES, LLC (US) 2015-04-14 US disclosed
US-20150004184-A1 ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME NULASTIN, INC. 2015-01-01 US disclosed
US-8871707-B2 Elastin producing fibroblast formulations and methods of using the same HUMAN MATRIX SCIENCES, LLC (US) 2014-10-28 US disclosed
US-8828927-B2 Elastin digest compositions and methods utilizing same HUMAN MATRIX SCIENCES, LLC (US) 2014-09-09 US disclosed
US-20130295122-A1 ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME NULASTIN, INC. 2013-11-07 US disclosed
US-8461113-B2 Elastin digest compositions and methods utilizing same HUMAN MATRIX SCIENCES, LLC (US) 2013-06-11 US disclosed
US-20110081322-A1 ELASTIN PRODUCING FIBROBLAST FORMULATIONS AND METHODS OF USING THE SAME NULASTIN, INC. 2011-04-07 US disclosed
US-7666829-B2 contains manganese chloride, manganese sulfate or manganese nitrate and ferric ammonium citrate or ferric chloride, for treating skin disorders; stimulating production of insoluble elastin, or deposition of collagen, fibroblasts; improve the appearance of scar; wrinkle resistance HUMAN MATRIX SCIENCES, LLC (US) 2010-02-23 US disclosed
US-20090281044-A1 ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME NULASTIN, INC. 2009-11-12 US disclosed